Results 271 to 280 of about 444,796 (301)

Acquisition of a multibasic cleavage site does not increase MERS-CoV entry into Calu-3 human lung cells. [PDF]

J Virol
Hoffmann M, Kleine-Weber H, Graichen L, Nehlmeier I, Kempf A, Moldenhauer A-S, Braun E, Assiri AM, Kirchhoff F, Sauter D, Alkharsah KR, Pöhlmann S.   +11 more
europepmc   +1 more source

MERS-CoV vaccine candidates in development: The current landscape

, 2016
Kayvon Modjarrad
openalex   +1 more source

Lung-Selective Delivery of mRNA-Encoding Anti-MERS-CoV Nanobody Exhibits Neutralizing Activity Both In Vitro and In Vivo. [PDF]

Vaccines (Basel)
Zhang Y, Tian C, Yu X, Yu G, Han X, Wang Y, Zhou H, Zhang S, Li M, Yang T, Sun Y, Tai W, Yin Q, Zhao G.   +13 more
europepmc   +1 more source

Low-Level Zoonotic Transmission of Clade C MERS-CoV in Africa: Insights from Scoping Review and Cohort Studies in Hospital and Community Settings. [PDF]

Viruses
Karani A, Ombok C, Situma S, Breiman R, Mureithi M, Jaoko W, Njenga MK, Ngere I.   +7 more
europepmc   +1 more source

Saudi Arabia's Middle East respiratory syndrome Coronavirus (MERS-CoV) outbreak: consequences, reactions, and takeaways. [PDF]

Ann Med Surg (Lond)
Salomon I.
europepmc   +1 more source

MERS-CoV spike vaccine-induced N-terminal domain-specific antibodies are more protective than receptor binding domain-specific antibodies. [PDF]

iScience
Abiona OM, Wang N, Leist SR, Schäfer A, Cockrell AS, Wang L, Bangaru S, Stevens L, Graham RL, Kocher JF, Tsybovsky Y, Kanekiyo M, Kumar A, Morabito KM, Rosen O, Shi W, Werner A, Zhang Y, Ziwawo C, Dzuvor CKO, Palandjian C, Eastman C, Matthews HR, Joseph J, Chappell JD, Kong WP, Mascola JR, Ward AB, Denison MR, Baric R, McLellan JS, Graham BS, Corbett-Helaire KS.   +32 more
europepmc   +1 more source

The role of diabetes in the severity of 2009 influenza A (H1N1) and the Middle East respiratory syndrome coronavirus (MERS-CoV): A systematic review and meta-analysis

, 2016
Alaa Badawi, Seung Gwan Ryoo
openalex   +1 more source

Mapping immunodominant sites on the MERS-CoV spike glycoprotein targeted by infection-elicited antibodies in humans. [PDF]

Cell Rep
Addetia A, Stewart C, Seo AJ, Sprouse KR, Asiri AY, Al-Mozaini M, Memish ZA, Alshukairi AN, Veesler D.   +8 more
europepmc   +1 more source